- Home
- NRIX vs ROG Comparison
NRIX vs ROG Comparison
Compare NRIX & ROG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRIX | ROG |
|---|---|---|
| Founded | 2009 | 1832 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.6B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | NRIX | ROG |
|---|---|---|
| Price | $25.37 | $126.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 3 |
| Target Price | $34.50 | ★ $193.33 |
| AVG Volume (30 Days) | ★ 1.9M | 189.9K |
| Earning Date | 10-12-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.26 | 0.25 |
| Revenue | $76,987,000.00 | ★ $879,091,000.00 |
| Revenue This Year | $786.93 | $7.61 |
| Revenue Next Year | N/A | $8.32 |
| P/E Ratio | ★ $7.82 | $514.36 |
| Revenue Growth | ★ 99.31 | 7.07 |
| 52 Week Low | $11.19 | $75.14 |
| 52 Week High | $28.23 | $169.00 |
Technical Indicators
Market Signals| Indicator | NRIX | ROG |
|---|---|---|
| Relative Strength Index (RSI) | 58.20 | 36.55 |
| Support Level | $24.61 | $122.12 |
| Resistance Level | $28.23 | $133.97 |
| Average True Range (ATR) | 1.21 | 4.97 |
| MACD | 0.39 | -2.61 |
| Stochastic Oscillator | 81.41 | 3.61 |
Price Performance
Historical ComparisonAbout NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
About ROG Rogers Corporation
Rogers Corp designs develop and manufactures engineered materials and components for sale to original equipment manufacturers and component suppliers. The firm operates in three business segments: Advanced Electronics Solutions, which manufactures circuit materials for applications in communications infrastructure, automotive, and consumer electronics markets; elastomeric material solutions, which provide cushioning, sealing, and impact protection in automotive, transportation, and construction applications; and Other, which consists of elastomer components for applications in the general industrial market, as well as elastomer floats for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets.